is tirzepatide being discontinued The FDA says the Zepbound shortage over. That's rattling the weight loss industry Real-World Use of GLP-1s Yields

PlexusDx provides compounded semaglutide injections starting at $149/mo, with personalized guidance on managing common adjustment symptoms

The phase 2 NEJM-published data showing up to 20% weight loss at 52 weeks with monthly injections and GI side effects concentrated at the first dose are particularly promising

Primary endpoint: change in body weight

Personalizing the Approach: Protocols That Work Functional providers can create tailored plans using: Supplement protocols to support appetite, energy, and blood sugar High-protein, nutrient-dense meals to prevent lean mass loss Time-restricted eating for glycemic control and satiety Movement prescriptions for muscle preservation and mitochondrial health Gut support for motility and microbiome balance These strategies help patients experience sustainable resultswhether theyre on GLP-1 meds, tapering off, or looking for a more natural path from the start

In a cohort of over 150,000 patients, the researchers identified no difference in the risk following initiation of different GLP-1 agents among these adults, despite the differences in systemic efficacy among the examined GLP-1 receptor agonist medications

Hypoglycemia (low blood sugar): While semaglutide itself typically does not cause low blood sugar, hypoglycemia can occur when it is used in combination with other glucose-lowering medications like insulin or sulfonylureas